Melatonin in osteosarcoma: an effective drug?
- 30 June 1997
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 48 (6) , 523-525
- https://doi.org/10.1016/s0306-9877(97)90123-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen aloneBritish Journal of Cancer, 1995
- A Randomized Study of Low-Dose Subcutaneous lnterleukin-2 Plus Melatonin versus Supportive Care Alone in Metastatic Colorectal Cancer Patients Progressing under 5-Fluorouracil and FolatesOncology, 1995
- Osteosarcoma and other tumors of boneCurrent Opinion in Oncology, 1994
- A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasmsCancer, 1994
- Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinomaEuropean Journal Of Cancer, 1994
- Osteogenic sarcoma with clinically detectable metastasis at initial presentation.Journal of Clinical Oncology, 1993
- Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancerBritish Journal of Cancer, 1992
- Circadian Rhythms in Serum Melatonin from Infancy to AdolescenceJournal of Clinical Endocrinology & Metabolism, 1985
- FALL IN NOCTURNAL SERUM MELATONIN DURING PREPUBERTY AND PUBESCENCEThe Lancet, 1984
- Hormonal Imbalance and the Sarcomata1Anz Journal of Surgery, 1969